Clinical cancer journals.

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung …

Clinical cancer journals. Things To Know About Clinical cancer journals.

Introduction. Colon and rectal cancer combined are the third most commonly diagnosed cancer worldwide [].In 2018, 1,849,518 new cases of colon or rectal cancer were diagnosed, with an additional 48,541 anal cancers diagnosed [].The highest incidence rates are in developed countries, such as Australia with 16,171 newly diagnosed colorectal … Convey. In the event of manuscript acceptance, each author, including the corresponding author, must complete a Conflict of Interest (COI) Disclosure questionnaire. American Cancer Society journals use Convey: A Global Disclosure System to facilitate the disclosure process. Journal of Clinical Medicine is an international, peer-reviewed, open access journal of clinical medicine, ... With the increasing incidence of thyroid cancer, understanding the anatomy and surgical techniques is crucial to ensure successful outcomes and minimize complications. This review discusses the anatomical considerations of the thyroid ...With an Impact Factor of 51·1, we are the world-leading clinical oncology research journal globally (2022 Journal Citation Reports ®, Clarivate 2023). We ...

* Cancer Research Communications has not published long enough to have received an Impact Factor. Five-Year Impact Factor: While the standard Impact Factor measures citations to journal articles published within a 2-year period, the 5-year Impact Factor evaluates citations to journal articles published within a 5 …Select an AACR Journal. The ten AACR journals vary in scope and selectivity. If you are unsure which journal would be most appropriate for your manuscript, please review the journal descriptions on this page.Detailed metrics, including the Impact Factors, of the AACR journals can be found at AACR Journals Metrics.. Editorial … Cancers is a peer-reviewed, open access journal of oncology, published semimonthly online by MDPI.The Irish Association for Cancer Research (IACR), Spanish Association for Cancer Research (ASEICA), Biomedical Research Centre (CIBM), British Neuro-Oncology Society (BNOS) and Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) are affiliated with Cancers and their members receive a discount on ...

Nov 8, 2023 · Acta Oncologica is owned by the non-for-profit Acta Oncologica Foundation and is the official scientific journal for the Nordic National Oncology Societies and the Nordic Association of Clinical Physics (NACP). Acta Oncologica provides a forum for the exchange of information on the etiology, prevention, diagnosis and treatment of all cancer types.

Clinical Cancer Investigation Journal. Print: 2278-1668, Online: 2278-0513. Current Issue. Year 2024 | Vol 13 | Issue 1. Article. Effect of Cisplatin Treatment on …Alcohol drinking is an established risk factor for several malignancies, and it is a potentially modifiable risk factor for cancer. The Cancer Prevention Committee of the American Society of Clinical Oncology (ASCO) believes that a proactive stance by the Society to minimize excessive exposure to alcohol has important implications for cancer …AACR Journals. Blood Cancer Discovery; Cancer Discovery; Cancer Epidemiology, Biomarkers & Prevention; Cancer Immunology Research; Cancer Prevention …Breast surgeon Liz O'Riordan shares her experience of being a doctor with breast cancer. Try our Symptom Checker Got any other symptoms? Try our Symptom Checker Got any other sympt...

Prostate cancer is a common type of cancer in men, according to the Mayo Clinic. It may grow slowly and it’s typically treatable. But hearing the words can still be scary. Here are...

A companion title to. Current Problems in Cancer: Case Reports is an international, peer-reviewed open access Journal publishing oncology case reports. It aims to share awareness of groundbreaking cases that give insight into redefining concepts in cancer. Our topics are comprehensive, encompassing new understandings ….

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials.Clinical Presentation (150-250 words). Briefly describe the clinical characteristics that result in a patient seeking medical care for the condition or what features of the disease should lead a physician to evaluate or treat it. Assessment and Diagnosis (250-300 words). Describe the clinical examination for evaluation of the disease …Nature Cancer publishes research, reviews and comment across the spectrum of the cancer field, from fundamental preclinical, to translational and clinical work.Read Volume 29 Issue 24 of Clinical Cancer Research. The cover shows a section of a bone marrow biopsy from a patient with multiple myeloma treated with pelareorep, bortezomib, and dexamethasone.A companion title to. Current Problems in Cancer: Case Reports is an international, peer-reviewed open access Journal publishing oncology case reports. It aims to share awareness of groundbreaking cases that give insight into redefining concepts in cancer. Our topics are comprehensive, encompassing new understandings ….

CA: A Cancer Journal for Clinicians is ACS' flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer. CA: A Cancer Journal for Clinicians: Vol 73, No 1Patients with spinal bone cancer have a median survival rate of 10 months, according to the Annals of Oncology journal. Once a patient experiences cord compression, the life expect...The articles published in The New England Journal of Medicine (NEJM), The Lancet, JAMA, BMJ, and some other journals in the oncology field, as well as the abstracts reported in the conferences of the American Society of Clinical Oncology (ASCO), the World Conference on Lung Cancer (WCLC), and the European Society for …Cancer Cell: journal: 12.578 Q1: 378: 192: 548: 7019: 12507: 426: 21.28: 36.56: 3: Cell Host and Microbe: journal: 10.227 Q1: 219: 208: 601: 9741: 11449: 522: …Clinical Cancer Research welcomes submission of the following article types to be considered for publication in the journal, subject to peer review as noted below for each type. Please see About Clinical Cancer Research for information about the journal, and Instructions for Authors for important policies and instructions relevant to all authors …Several clinical trials have been carried out using p53 vaccines. In a clinical trial by Kuball et al, six patients with advanced-stage cancer were given vaccine containing a recombinant replication-defective adenoviral vector with human wild-type p53. When followed up at 3 months post immunisation, four out of the six patients had stable …

Scope. Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, and molecular alterations or biomarkers that predict response or resistance ... Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all ...

Mar 13, 2024 · Locally advanced mismatch repair-deficient gastroesophageal junction cancer: Diagnosis, treatment modifications, and monitoring. Rutika Mehta MD, MPH, Andrew Sinnamon MD, Aamir Dam MD, Christine Walko PharmD, BCOP, Russell Palm MD, Laura Barton MS, Gregory Lauwers MD, Jose M. Pimiento MD. Pages: 123-131. About the Journal. Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials.Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. Through research, education, and promotion of the highest-quality, equitable patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and …MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness. Margherita Puppo. , Manoj Kumar Valluru. & Philippe Clézardin.Journal of Experimental & Clinical Cancer Research is a top rated Springer Nature journal. Prof. Mauro Castelli and the editorial team performed in the top percentile of journals based on data collected from the Journal Author Satisfaction Survey. We are recognising extraordinary editors for their commitment and passion to their journals.In this paper, the epidemiological characteristics, developmental trends, and risk factors of pancreatic cancer are reviewed and analyzed in detail. Keywords: Pancreatic cancer, Epidemiology, Trend, Risk factors, Pancreatic ductal adenocarcinoma. Core Tip: Pancreatic cancer is still a highly lethal gastrointestinal cancer with a low 5-year ...Breast cancer is usually discovered in one of two ways. A woman might find some signs irregularities in her breasts, or her doctor identifies some clinical symptoms during a routin...In 2020 breast cancer mortality-to-incidence ratio (MIR) as a representative indicator of 5-year survival rates was 0.30 globally . Taking into consideration the clinical extent of breast cancer, in locations with developed health care (Hong-Kong, Singapore, Turkey) the 5-year survival was 89.6% for localized …Nov 4, 2023 · CA: A Cancer Journal for Clinicians is ACS' flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer. CA: A Cancer Journal for Clinicians: Vol 73, No 6 Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all ...

Explore the latest in cancer science including checkpoint inhibitors, DCIS, breast prostate and lung cancer treatment, aspirin prevention, biomarkers, and more. [Skip to Navigation] ... Resource Center Best of the JAMA Network Caring for the Critically Ill Patient Clinical Crosswords from JAMA Coronavirus Resource Center Evidence-Based …

Alaunos Therapeutics Inc (NASDAQ:TCRT) announced early clinical findings from its ongoing TCR-T Library Phase 1/2 trial. "We ... Indices Commodities Currencies ...

Apr 19, 2022 · In San Antonio, Texas, Anthony Tolcher has been a principal investigator for 20 phase 1 clinical studies of FDA-approved cancer drugs, but he is now most excited by antibody–drug conjugates ... Explore the latest in cancer science including checkpoint inhibitors, DCIS, breast prostate and lung cancer treatment, aspirin prevention, biomarkers, and more. [Skip to Navigation] ... Resource Center Best of the JAMA Network Caring for the Critically Ill Patient Clinical Crosswords from JAMA Coronavirus Resource Center Evidence-Based …About the Journal. Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanism of drug resistance, biomarkers of drug response, novel models and technologies, and occasional drug …S. Woloshin and Others. N Engl J Med 2023;389:1061-1064. The evidence for breast cancer screening of women in their 40s is insufficient to support a new public health imperative, given the ...Published by Medical Journals Sweden from 2024. Acta Oncologica is an international peer-reviewed journal based in the Nordic countries. The journal welcomes international contributions and offers global reach. Acta Oncologic a provides the scientific community with a platform for innovative, comprehensive and clinically relevant cancer …The Journal covers all aspects of the clinical management of cancer patients and its authors are drawn from leading international centres. The Journal features … Our family of 50+ titles provides breadth and depth of coverage from basic to translational to clinical research, across all cancer types, with a wide variety of open access options. It’s a comprehensive portfolio of titles; in fact, between them, our oncology network journals publish 18 percent of all papers in the field. Abstract. Prostate cancer is a common malignancy seen worldwide. The incidence has risen in recent decades, mainly fuelled by more widespread use of prostate-specific antigen (PSA) testing, although prostate cancer mortality rates have remained relatively static over that time period. A man’s risk of prostate …Pancreatic cancer is a deadly disease with complex etiology, diagnosis, and treatment. This article reviews the current knowledge and challenges of risk factors, biomarkers, imaging, and therapeutic options for pancreatic cancer, and provides insights for future research and clinical practice.News & Views 20 Mar 2024 Nature Reviews Clinical Oncology. P: 1-2. ... Correspondence Open Access 06 Mar 2024 Blood Cancer Journal. Volume: 14, P: 39. Learning from cancer mutations.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics. Explore breast cancer research in npj Breast Cancer, an open access journal with 5.9 Impact ...A clinical trial in oncology is a research study investigating the safety and effectiveness of an intervention to potentially improve outcomes for patients with cancer. They test new therapies, treatment approaches, and diagnostic or screening methods. Trials for new therapies follow a process from phase 1 to phase 4.Cancers is a peer-reviewed, open access journal of oncology, published semimonthly online by MDPI.The Irish Association for Cancer Research (IACR), Spanish Association for Cancer Research (ASEICA), Biomedical Research Centre (CIBM), British Neuro-Oncology Society (BNOS) and Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) are …As per prior literature investigating the impact of obesity on cancer treatment outcomes and survival [5, 7], the underweight subgroup (4% of total …Instagram:https://instagram. hdfc bank internet bankingwww amerisbank comgolden nugget online casino paalpha gym Scientists are still optimistic about using Crispr medicinally, despite two troubling papers published this week in a leading scientific journal. The biotech industry is obsessed w... uber frieghtsilent hill watch The New England Journal of Medicine: Research & Review Articles on Disease & Clinical Practice. Original Article Multitarget Stool DNA Test for Colorectal Cancer T.F. Imperiale and Others. In ...0732-183X. 7475. American Society of Clinical Oncology. Journal of the National Cancer Institute. 1052-6773. 5300. Oxford University Press. Cancer and Metastasis Reviews. 0167-7659. zone of interest full movie Clinical Cancer Bulletin is an open access journal covering issues relevant to clinical cancer specialists worldwide. Strives to report original, innovative, high …Targeted therapies have swiftly taken a prominent position in cancer research and clinical oncology in recent decades, thanks to the molecular insights into oncogenic processes and mechanisms ...Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the third most common cause of cancer‐related death in both men and women in the United States. CRC is rapidly shifting to diagnosis at a younger age and at a more advanced stage; however, a large proportion of CRC incidence and mortality is preventable …